Your browser doesn't support javascript.
loading
Correlation of severity & clinical outcomes of COVID-19 with virus variants: A prospective, multicentre hospital network study.
Wadhwa, Komal; Malik, Shilpa; Balaji, Srinigila; Thiruvengadam, Ramachandran; Bashyam, Murali Dharan; Bhattacharya, Prasanta Kumar; Behera, Bijayini; Bhardwaj, Pankaj; Biswas, Nidhan K; Das, Asim; Dey, Anindya; Dhotre, Dhiraj; Dias, Mary; Dubey, Pankaj; Dutta, Shreelekha; Gadepalli, Ravisekhar; Gosain, Mudita; Goud, Kalal Iravaty; Gupta, Neeraj Kumar; Gupta, Nitesh; Jana, Pradipta; Jena, Deepak; John, Elizabeth; Karunanidhi, Arunkumar; Khan, S Muhammad Salim; Khattar, Sahil; Paul, Abhilash Prabhakar Kundavaram; Kumar, Shakti; Maitra, Arindam; Modi, Nikhil; Moorthy, Mahesh; Nagaraj, Savitha; Palakodeti, Dasaradhi; Pandey, Anil Kumar; Pandey, Aparna; Raghav, Sunil Kumar; Ramasubban, Suresh; Raghavan, Sreevatsan; Harikrishnan, S; Krishnamoorthy, S; Selvamurugan, Selvaraj; Sardana, Raman; Shouche, Yogesh; Singh, Akanksha; Singh, Arvind Kumar; Ramasubramaniyan, V; Yadav, Monika; Zahoor, Danish; Narreddy, Suneetha; Bhatnagar, Shinjini.
Afiliación
  • Wadhwa K; Clinical Development Services Agency, Faridabad, Haryana, India.
  • Malik S; Clinical Development Services Agency, Faridabad, Haryana, India.
  • Balaji S; Clinical Development Services Agency, Faridabad, Haryana, India.
  • Thiruvengadam R; Center for Maternal and Child Health, Faridabad, Haryana, India.
  • Bashyam MD; Laboratory of Molecular Oncology, Hyderabad, Telangana, India.
  • Bhattacharya PK; Department of General Medicine, North Eastern Indira Gandhi Regional Institute, Shillong, Meghalaya, India.
  • Behera B; Department of Microbilogy, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
  • Bhardwaj P; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
  • Biswas NK; National Institute of Biomedical Genomics, Kalyani, India.
  • Das A; ESIC Medical College & Hospital, Faridabad, Haryana, India.
  • Dey A; Department of Microbiology, Apollo Hospitals, Kolkata, West Bengal, India.
  • Dhotre D; National Centre for Cell Science, Pune, Maharashtra, India.
  • Dias M; National Centre for Cell Science, Pune, Maharashtra, India.
  • Dubey P; Department of Critical Care, Apollo Hospitals, Ahmedabad, Gujarat, India.
  • Dutta S; National Institute of Biomedical Genomics, Kalyani, India.
  • Gadepalli R; Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
  • Gosain M; Center for Maternal and Child Health, Faridabad, Haryana, India.
  • Goud KI; Molecular Biology and Cytogenetics, Apollo Hospitals, Hyderabad, Telangana, India.
  • Gupta NK; Department of Pulmonary Critical Care and Sleep Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
  • Gupta N; Department of Pulmonary Critical Care and Sleep Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
  • Jana P; Infection and Immunology, Faridabad, Haryana, India.
  • Jena D; Department ofImmunogenomics & Systems Biology Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India.
  • John E; Institute for Stem Cell Science & Regenerative Medicine, Bengaluru, Karnataka, India.
  • Karunanidhi A; Centre for DNA Fingerprinting & Diagnostics, Hyderabad, Telangana, India.
  • Khan SMS; Department of Community Medicine, Government Medical College, Srinagar, Jammu & Kashmir, India.
  • Khattar S; Center for Data Management, Faridabad, Haryana, India.
  • Paul APK; Emergency Department, Christian Medical College, Vellore, Tamil Nadu, India.
  • Kumar S; Infection and Immunology, Faridabad, Haryana, India.
  • Maitra A; National Institute of Biomedical Genomics, Kalyani, India.
  • Modi N; Department of Respiratory Critical Care and Sleep Medicine, Apollo Hospitals, New Delhi, India.
  • Moorthy M; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
  • Nagaraj S; Department of Microbiology, St. Johns Medical College & Hospital, Bengaluru, Karnataka, India.
  • Palakodeti D; Institute for Stem Cell Science & Regenerative Medicine, Bengaluru, Karnataka, India.
  • Pandey AK; Medical Superindent, ESIC Medical College & Hospital, Faridabad, Haryana, India.
  • Pandey A; Department of Microbiology, ESIC Medical College & Hospital, Faridabad, Haryana, India.
  • Raghav SK; Department ofImmunogenomics & Systems Biology Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India.
  • Ramasubban S; Department of Critical care, Apollo Hospitals, Kolkata, West Bengal, India.
  • Raghavan S; Center for Maternal and Child Health, Faridabad, Haryana, India.
  • Harikrishnan S; Department of Pulmonology, Apollo Hospitals, Madurai, Tamil Nadu, India.
  • Krishnamoorthy S; Department of Internal Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.
  • Selvamurugan S; Department of Clinical Research, Apollo Hospitals, Madurai, Tamil Nadu, India.
  • Sardana R; Department of Microbiology, Apollo Hospitals, New Delhi, India.
  • Shouche Y; National Centre for Microbiol Resource, Pune, Maharashtra, India.
  • Singh A; Clinical Development Services Agency, Faridabad, Haryana, India.
  • Singh AK; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
  • Ramasubramaniyan V; Department of Infectious Diseases and Tropical Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.
  • Yadav M; Clinical Development Services Agency, Faridabad, Haryana, India.
  • Zahoor D; Department of Microbiology, Government Medical College, Srinagar, Jammu & Kashmir, India.
  • Narreddy S; Departments of Infectious Medicine, Apollo Hospitals, Hyderabad, Telangana, India.
  • Bhatnagar S; Center for Maternal and Child Health, Faridabad, Haryana, India.
Indian J Med Res ; 159(1): 91-101, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-38344919
ABSTRACT
BACKGROUND

OBJECTIVES:

The clinical course of COVID-19 and its prognosis are influenced by both viral and host factors. The objectives of this study were to develop a nationwide platform to investigate the molecular epidemiology of SARS-CoV-2 (Severe acute respiratory syndrome Corona virus 2) and correlate the severity and clinical outcomes of COVID-19 with virus variants.

METHODS:

A nationwide, longitudinal, prospective cohort study was conducted from September 2021 to December 2022 at 14 hospitals across the country that were linked to a viral sequencing laboratory under the Indian SARS-CoV-2 Genomics Consortium. All participants (18 yr and above) who attended the hospital with a suspicion of SARS-CoV-2 infection and tested positive by the reverse transcription-PCR method were included. The participant population consisted of both hospitalized as well as outpatients. Their clinical course and outcomes were studied prospectively. Nasopharyngeal samples collected were subjected to whole genome sequencing to detect SARS-CoV-2 variants.

RESULTS:

Of the 4972 participants enrolled, 3397 provided samples for viral sequencing and 2723 samples were successfully sequenced. From this, the evolution of virus variants of concern including Omicron subvariants which emerged over time was observed and the same reported here. The mean age of the study participants was 41 yr and overall 49.3 per cent were female. The common symptoms were fever and cough and 32.5 per cent had comorbidities. Infection with the Delta variant evidently increased the risk of severe COVID-19 (adjusted odds ratio 2.53, 95% confidence interval 1.52, 4.2), while Omicron was milder independent of vaccination status. The independent risk factors for mortality were age >65 yr, presence of comorbidities and no vaccination. INTERPRETATION

CONCLUSIONS:

The authors believe that this is a first-of-its-kind study in the country that provides real-time data of virus evolution from a pan-India network of hospitals closely linked to the genome sequencing laboratories. The severity of COVID-19 could be correlated with virus variants with Omicron being the milder variant.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Indian J Med Res Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Indian J Med Res Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: India